Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | VRCA | AQST | ||
| Company | Akebia Therapeutics | Verrica Pharmaceuticals Inc | Aquestive Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.3500 | 6.79 | 3.93 | ||
| High | 1.3500 | 6.95 | 4.01 | ||
| Low | 1.3100 | 6.65 | 3.78 | ||
| Last | 1.3201 | 6.64 | 3.93 | ||
| Change | -0.0499 | -0.15 | +0.03 | ||
| % Change | -3.64% | -2.21% | +0.77% | ||
| Volume | 1,935,374 | 212,563 | 1,493,850 | ||
| 20-Day Average Volume | 7,285,876 | 174,784 | 2,648,151 | ||
| Previous Close | 1.3700 | 6.79 | 3.90 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4750 | 6.71 | 4.11 | ||
| 20-Day Raw Stochastic | 0.85% | 66.09% | 26.22% | ||
| 20-Day Relative Strength | 40.69% | 59.44% | 48.38% | ||
| Weighted Alpha | +10.58 | +0.01 | +80.86 | ||
| Today's Opinion | 8% Sell | 100% Buy | 56% Buy | ||
| Previous Opinion | 24% Buy | 100% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.04% since 04/18/24 | -2.46% since 04/18/24 | -12.56% since 04/18/24 | ||
| Low | 1.3100 on 04/25/24 | 6.57 on 04/22/24 | 3.78 on 04/25/24 | ||
| High | 1.4100 on 04/23/24 | 7.01 on 04/19/24 | 4.54 on 04/19/24 | ||
| 1-Month | |||||
| %Chg | -40.27% since 03/25/24 | +33.00% since 03/25/24 | -5.86% since 03/25/24 | ||
| Low | 1.3100 on 04/25/24 | 4.78 on 03/26/24 | 3.72 on 04/16/24 | ||
| High | 2.4800 on 03/28/24 | 7.32 on 04/10/24 | 4.54 on 04/19/24 | ||
| 3-Month | |||||
| %Chg | -12.00% since 01/25/24 | +18.90% since 01/25/24 | +66.03% since 01/25/24 | ||
| Low | 1.3100 on 04/25/24 | 4.60 on 03/20/24 | 2.33 on 01/26/24 | ||
| High | 2.4800 on 03/28/24 | 7.32 on 04/10/24 | 6.23 on 03/18/24 | ||
| 6-Month | |||||
| %Chg | +65.00% since 10/25/23 | +78.99% since 10/25/23 | +181.07% since 10/25/23 | ||
| Low | 0.7801 on 10/26/23 | 2.86 on 11/14/23 | 1.37 on 10/26/23 | ||
| High | 2.4800 on 03/28/24 | 7.51 on 12/27/23 | 6.23 on 03/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 286,840 | 288,032 | 285,874 | ||
| Shares Outstanding, K | 209,372 | 42,420 | 73,301 | ||
| Annual Sales | 194,620,000 | 5,120,000 | 50,580,000 | ||
| Annual Net Income | -51,930,000 | -67,000,000 | -7,870,000 | ||
| Last Quarter Sales | 56,070,000 | 1,990,000 | 13,210,000 | ||
| Last Quarter Net Income | -50,000 | -24,610,000 | -8,110,000 | ||
| 60-Month Beta | 0.79 | 1.88 | 2.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/14/24 | -0.48 on 02/29/24 | -0.12 on 03/05/24 | ||
| Latest Earnings Date | 05/13/24 | 05/14/24 | 05/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||